Modeling Epidermolysis Bullosa Simplex With Cardiomyopathy Using KLHL24-Mutant Pluripotent Stem Cells

The study investigates the use of KLHL24-mutant pluripotent stem cells to model epidermolysis bullosa simplex (EBS) with cardiomyopathy. This research aims to better understand the pathophysiology of EBS, a genetic skin disorder, and its association with heart disease. By utilizing patient-derived stem cells, the study provides insights into the cellular mechanisms underlying these conditions, potentially paving the way for new therapeutic strategies. The collaboration involves multiple international research centers, highlighting the global effort to address this complex genetic disorder.